Xtl Biopharma ADR (XTLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 820 | 1,068 | 1,401 | 1,457 | 1,589 |
| Marketable Securities | 900 | 1,271 | 605 | 749 | 794 |
| Receivables | 140 | 150 | N/A | N/A | N/A |
| Other current assets | 127 | 59 | 40 | 77 | 118 |
| TOTAL | $1,987 | $2,548 | $2,046 | $2,283 | $2,501 |
| Non-Current Assets | |||||
| PPE Net | 217 | N/A | N/A | N/A | N/A |
| Intangibles | 7,076 | 380 | 380 | 380 | 380 |
| TOTAL | $7,293 | $380 | $380 | $380 | $380 |
| Total Assets | $9,280 | $2,928 | $2,426 | $2,663 | $2,881 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 168 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 554 | 223 | 206 | 162 | 163 |
| Other current liabilities | 1,745 | N/A | N/A | N/A | N/A |
| TOTAL | $2,467 | $223 | $206 | $162 | $163 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 765 | 0 | 0 | 0 | 0 |
| TOTAL | $1,096 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $3,563 | $223 | $206 | $162 | $163 |
| Shareholders' Equity | |||||
| Common Shares | 23,138 | 14,120 | 14,120 | 14,120 | 14,120 |
| Retained earnings | -158,766 | -157,761 | -158,246 | -157,965 | -157,748 |
| Other shareholders' equity | 20 | 20 | 20 | 20 | 20 |
| TOTAL | $5,717 | $2,705 | $2,220 | $2,501 | $2,718 |
| Total Liabilities And Equity | $9,280 | $2,928 | $2,426 | $2,663 | $2,881 |